Zoledronic Acid Combined Radiotherapy for Bone Metastasis of Non-small Cell Lung Cancer
Status:
Not yet recruiting
Trial end date:
2022-12-01
Target enrollment:
Participant gender:
Summary
This study will give comparison of the bone pain remission and the adverse reaction of
Zoledronic acid combine with High dose fractionation radiotherapy(30Gy/10f) and Zoledronic
acid combine with low dose fractionation radiotherapy(15Gy/5f) . The purpose of this trial is
to prove whether Zoledronic acid combine radiotherapy can reduce radiotherapy dose in
treatment of non-small cell lung cancer bone metastasis'pain relief or not.
Phase:
Phase 4
Details
Lead Sponsor:
Daping Hospital and the Research Institute of Surgery of the Third Military Medical University